Omnicell Achieves International ISO Environmental Certification
Company reinforces commitment to corporate responsibility through all facets of the business
MOUNTAIN VIEW, Calif., April 1, 2014 /PRNewswire/ — Today Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare providers, announced it achieved certification for International Organization for Standardization (ISO) 14001:2004 Environmental Management System (EMS), demonstrating the company’s commitment to lowering its environmental impact. The EMS is a framework that helps a company achieve its environmental goals through consistent control of its operations.
“Omnicell is committed to environmental stewardship and is extremely proud of our team for achieving the ISO 14001:2004 accreditation reinforcing the company’s commitment to responsible environmental business practices on a global level,” said Robert Smith, senior director, quality and regulatory affairs at Omnicell. “By adhering to this global standard we are helping to reduce costs, meet customer expectations and minimize the impact Omnicell has on the environment.”
Omnicell’s ISO 14001:2004 certification was obtained in Dec., 2013, following an on-site certification audit by TUV Rheinland.
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum– from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
More than 2,800 Acute Care customers worldwide have utilized Omnicell’s medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com.
OMCL – G
1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website. 2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc. 3. All other brand or product names may be trademarks or registered trademarks of their respective companies.
SOURCE Omnicell, Inc.